plus_logo.png
Plus Therapeutics Regains Compliance with Nasdaq Minimum Stockholders’ Equity Requirement
March 10, 2025 07:30 ET | Plus Therapeutics Inc.
Plus Therapeutics Regains Compliance with Nasdaq Minimum Stockholders’ Equity Requirement
Music of Your Life Launches Street Talk
March 07, 2025 10:59 ET | The Marquie Group, Inc.
TMGI subsidiary Music of Your Life launches syndicated radio program as company continues focuse on cancer awareness.
plus_logo.png
Plus Therapeutics Announces Peer-Reviewed Publication in Nature Communications Highlighting Promising Phase 1 Results for Rhenium (186Re) Obisbemeda in Glioblastoma
March 07, 2025 07:30 ET | Plus Therapeutics Inc.
Plus Therapeutics Announces Peer-Reviewed Publication in Nature Communications Highlighting Promising Phase 1 Results for Rhenium (186Re) Obisbemeda
plus_logo.png
Plus Therapeutics Announces New Employment Inducement Grants
March 05, 2025 16:01 ET | Plus Therapeutics Inc.
Plus Therapeutics Announces New Employment Inducement Grants
Siren Bio Logo with Name.png
Siren Biotechnology Expands Clinical and Scientific Advisory Board with Key Industry Leaders
March 05, 2025 12:15 ET | Siren Biotechnology, Inc.
Siren Biotechnology expands Clinical and Scientific Advisory Board with key industry leaders
plus_logo.png
Plus Therapeutics Secures Private Placement of Approximately $15 Million in Gross Proceeds
March 04, 2025 14:06 ET | Plus Therapeutics Inc.
Plus Therapeutics Secures Private Placement of Approximately $15 Million in Gross Proceeds
irazu-oncology-logo.png
Irazú Oncology Secures Bridge Funding, Expands Leadership Team and Facilities
March 04, 2025 08:30 ET | Irazu Oncology
Dr. Mayukh Das, joined Irazú as CMO, bringing extensive oncology drug development experience from leadership roles at global pharmaceutical companies.
Tumor Ablation Market to Reach $7.5 billion, Globally, by 2035 at 13.6% CAGR: Allied Market Research
March 04, 2025 06:30 ET | Allied Market Research INC
Wilmington, Delaware, March 04, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Tumor Ablation Market by Technology (Radiofrequency Ablation, Microwave Ablation,...
Cardiff.jpg
Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update
February 27, 2025 16:05 ET | Cardiff Oncology, Inc.
- Robust initial efficacy signal with onvansertib + chemo/bev in ongoing first-line RAS-mut metastatic colorectal cancer (“mCRC”) clinical trial (CRDF-004) - - Priced oversubscribed $40...
Georgina Rodríguez's Visit to Children at KFNCCC - 2
KFNCCC Welcomes Georgina Rodríguez's Visit to Support Young Cancer Patients
February 27, 2025 06:51 ET | King Faisal Specialist Hospital & Research Centre
KFNCCC Welcomes Georgina Rodríguez's Visit to Support Young Cancer Patients